After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Adverum Biotechnologies Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Adverum Biotechnologies Inc is $90.02M. A total of 0.52 million shares were traded on the day, compared to an average of 563.35K shares.
In the most recent transaction, Soparkar Peter sold 2,960 shares of ADVM for 2.00 per share on May 15 ’25. After the transaction, the CHIEF OPERATING OFFICER now owns 39,154 company shares. In a previous transaction on May 15 ’25, Seyedkazemi Setareh sold 924 shares at 2.00 per share. ADVM shares that CHIEF DEVELOPMENT OFFICER owns now total 13,768.
Among the insiders who sold shares, Fischer Laurent disposed of 9,126 shares on May 15 ’25 at a per-share price of $2.00. This resulted in the CEO, PRESIDENT AND DIRECTOR holding 87,488 shares of ADVM after the transaction. In another insider transaction, Leonard Braden Michael bought 20,407 shares at $5.04 per share on Mar 26 ’25. Company shares held by the 10% Owner now total 125,207.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ADVM has a high of $8.18 and a low of $1.78.
As of this writing, ADVM has an earnings estimate of -$1.68 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.84 per share and a lower estimate of -$2.45. The company reported an EPS of -$1.3 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ADVM’s latest balance sheet shows that the firm has $305.19M in Cash & Short Term Investments as of fiscal 2021. There were $102.99M in debt and $21.32M in liabilities at the time. Its Book Value Per Share was -$0.96, while its Total Shareholder’s Equity was $316.19M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADVM is Buy with a score of 3.86.
